PubMedCrossRef 18. Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK: Human dendritic cell subsets for vaccination. Journal of clinical immunology 2005, 25:551–72.PubMedCrossRef 19. Chen M, Huang L, Shabier Z, Wang J: Regulation of the lifespan in dendritic cell subsets. Molecular immunology 2007, 44:2558–65.PubMedCrossRef 20. Dudziak D, Salubrinal nmr Kamphorst AO, Heidkamp GF, et al.: Differential antigen processing by dendritic cell subsets in vivo. Science (New
York, NY) 2007, 315:107–11.CrossRef 21. Colonna M, Trinchieri G, Liu YJ: Plasmacytoid dendritic Combretastatin A4 cells in immunity. Nature immunology 2004, 5:1219–26.PubMedCrossRef 22. Kadowaki N, Ho S, Antonenko S, et al.: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. The Journal of experimental medicine 2001, 194:863–9.PubMedCrossRef 23. Wojas K, Tabarkiewicz J, Jankiewicz M, Rolinski J: Dendritic cells learn more in peripheral blood of patients with breast and lung cancer–a pilot study. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2004, 42:45–8.PubMed 24. Ferrari S, Malugani F, Rovati B, Porta C, Riccardi A, Danova M: Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients. Oncology reports 2005, 14:113–20.PubMed 25. Maecker B, Mougiakakos D, Zimmermann
M, et al.: Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients. Leukemia 2006, 20:645–9.PubMedCrossRef 26. Dickson J, Davidson SE, Hunter RD, West CM: Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the
cervix. International journal of radiation oncology, biology, physics 2000, 48:991–5.PubMedCrossRef Resminostat 27. Ratta M, Fagnoni F, Curti A, et al.: Dendritic cells are functionally defective in multiple myeloma the role of interleukin-6. Blood 2002, 100:230–7.PubMedCrossRef 28. Walsh SV, Hopkins AM, Nusrat A: Modulation of tight junction structure and function by cytokines. Advanced drug delivery reviews 2000, 41:303–13.PubMedCrossRef 29. Beckebaum S, Zhang X, Chen X, et al.: Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004, 10:7260–9.PubMedCrossRef 30. Saito T, Dworacki G, Gooding W, Lotze MT, Whiteside TL: Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma. Clin Cancer Res 2000, 6:1351–64.PubMed 31. Curiel TJ, Coukos G, Zou L, et al.: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature medicine 2004, 10:942–9.PubMedCrossRef 32. Sombroek CC, Stam AG, Masterson AJ, et al.